Thats the problem for me Hesk. They honestly believe what they are doing is the best way. They seem to be constantly surprised when they find out no one is interested, and they dont seem to be able to work out why. I say this again because of all the previous deals and collaborations they either thought were about to be signed or about to convert to milestones. Pretty much none ever occured.
I would rather they consider right now if mouse model of disease is enough to generate interest in cpp. I say this because if this is not enough then there is no question there will be another cr and huge dilution. Are you happy to just sit and wait for that?
Lets face it as far as i am aware they have proven they can show endosomal escape of cpp, which was supposed to be the holy grail, yet since then which must now be more than a year ago it appears no significant collaboration or opportunity has been generated by this revalation. Despite the full calendar of presentations they have made since. . I hope they are fully aware of what data big pharma want but past history sats maybe not??
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)